Article Information
History
- January 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Emily Stephenson*,1,
- Gary Reynolds*,1,
- Rachel A Botting*,1,
- Fernando J Calero-Nieto*,2,
- Michael Morgan*,3,4,
- Zewen Kelvin Tuong*,5,6,
- Karsten Bach*,3,4,
- Waradon Sungnak*,6,
- Kaylee B Worlock7,
- Masahiro Yoshida7,
- Natsuhiko Kumasaka6,
- Katarzyna Kania4,
- Justin Engelbert1,
- Bayanne Olabi1,
- Jarmila Stremenova Spegarova8,
- Nicola K Wilson2,
- Nicole Mende2,
- Laura Jardine1,
- Louis CS Gardner1,
- Issac Goh1,
- Dave Horsfall1,
- Jim McGrath1,
- Simone Webb1,
- Michael W. Mather1,
- Rik GH Lindeboom6,
- Emma Dann6,
- Ni Huang6,
- Krzysztof Polanski6,
- Elena Prigmore6,
- Florian Gothe8,
- Jonathan Scott8,
- Rebecca P Payne8,
- Kenneth F Baker8,9,
- Aidan T Hanrath8,10,
- Ina CD Schim van der Loeff8,
- Andrew S Barr10,
- Amada Sanchez-Gonzalez10,
- Laura Bergamaschi11,12,
- Federica Mescia11,12,
- Josephine L Barnes7,
- Eliz Kilich13,
- Angus de Wilton13,
- Anita Saigal14,
- Aarash Saleh14,
- Sam M Janes7,13,
- Claire M Smith15,
- Nusayhah Gopee1,16,
- Caroline Wilson1,17,
- Paul Coupland4,
- Jonathan M Coxhead1,
- Vladimir Y Kiselev6,
- Stijn van Dongen6,
- Jaume Bacardit18,
- Hamish W King6,19,
- Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration,
- Anthony J Rostron8,
- A John Simpson8,
- Sophie Hambleton8,
- Elisa Laurenti2,
- Paul A Lyons11,12,
- Kerstin B Meyer6,†,
- Marko Z Nikolic7,13,†,
- Christopher JA Duncan8,10,†,
- Ken Smith11,12,†,
- Sarah A Teichmann6,21,†+,
- Menna R Clatworthy5,12,20,22,†+,
- John C Marioni3,4,6,†+,
- Berthold Gottgens2,†+ and
- Muzlifah Haniffa1,6,9,16,†+
- 1Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK
- 2Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK
- 3European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK
- 4Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
- 5Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK
- 6Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
- 7UCL Respiratory, Division of Medicine, University College London, London, UK
- 8Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
- 9NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
- 10Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation, UK
- 11Cambridge Institute for Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, UK
- 12Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, UK
- 13University College London Hospitals NHS Foundation Trust, London, UK
- 14Royal Free Hospital NHS Foundation Trust, London, UK
- 15UCL Great Ormond Street Institute of Child Health, London, UK
- 16Department of Dermatology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
- 17The Innovation Lab Integrated Covid Hub North East, Newcastle Upon Tyne, UK
- 18School of Computing, Newcastle University, Newcastle Upon Tyne, UK
- 19Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London UK
- 20Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge Biomedical Campus, Cambridge, UK
- 21Theory of Condensed Matter Group, Cavendish Laboratory/Department of Physics, University of Cambridge, Cambridge, UK
- 22NIHR Cambridge Biomedical Research Centre, Cambridge, UK
- ↵+Correspondence to: m.a.haniffa{at}ncl.ac.uk, bg200{at}cam.ac.uk, marioni{at}ebi.ac.uk, mrc38{at}cam.ac.uk, st9{at}sanger.ac.uk
↵* equal contribution